7506
H. Mizufune et al. / Tetrahedron 57 02001) 7501±7506
4.2.3. Spiro[6-bromo-7-chloro-4-/2-pyridyl)-2H-1,3-benzox-
azine-2,40-/10-methylpiperidine)] /10d). A colorless crys-
talline powder: mp 155±1568C, H NMR /CDCl3, TMS,
300 MHz), d /ppm): 2.05±2.18 /4H, m), 2.37 /3H, s),
2.46±2.54 /2H, m), 2.66±2.73 /2H, m), 7.08 /1H, s),
7.38±7.43 /1H, m), 7.80±7.91 /2H, m), 8.14 /1H, s),
8.68±8.70 /1H, m), IR /KBr, cm21) 2798, 1589, 1010, MS
/EI, m/z): 409 /M14), 407 /M12), 405 /M), Elemental
analysis: calcd for C18H17N3OBrCl; C: 53.16, H: 4.21, N:
10.33, found for C: 53.41, H: 4.30, N: 10.67.
4.2.7. Synthesis of benzoxazine /10e) via ketimine /9)
derived benzoylpyrodine /8) and ammonia gas. In the
stirred suspension of EtOH /400 ml) and CaSO4
/Drieritee) /20 g), ammonia gas was bubbled for 1 h at
0±108C. To the resulting mixture was added 2-/5-bromo-
4-chloro-2-hydroxybenzoyl)pyridine 8 /20 g, 64 mmol) and
stirred at room temperature for 1.5 h. The insoluble matter
in the reaction mixture was ®ltered off and washed with
EtOH. The mixture of the ®ltrate and washings was concen-
trated in vacuo to give the crude ketimine /9) /17.8 g) as a
yellow solid: MS /EI, m/z): 314 /M14), 312 /M12), 310
/M), Elemental analysis: calcd for C12H8N2OBrCl; C: 49.26,
H: 2.59, N: 8.99, found for C: 46.03, H: 2.62, N: 8.33.
1
4.2.4. Spiro[6-bromo-7-chloro-4-/2-pyridyl)-2H-1,3-benzox-
azine-2,20-adamantane] /10e). A colorless crystalline
powder: mp 145±1468C, 1H NMR /CDCl3, TMS,
300 MHz), d /ppm): 1.58±1.78 /6H, m), 1.93±1.97 /2H,
m), 2.22±2.26 /4H, m), 2.36±2.40 /2H, m), 7.10 /1H, s),
7.37±7.42 /1H, m), 7.80±7.86 /1H, m), 7.98±8.01 /1H, m),
8.22 /1H, s), 8.67±8.69 /1H, m), IR /KBr, cm21) 2904,
1590, 1006, MS /EI, m/z): 446 /M14), 444 /M12), 442
/M), Elemental analysis: calcd for C22H20N2OBrCl; C:
59.54, H: 4.54, N: 6.31, found for C: 59.57, H: 4.59, N: 6.37.
Morpholine hydrochloride /9.89 g, 80 mmol) was added to
the stirred suspension of the crude ketimne /4.99 g,
32 mmol), 3,4-dimethoxybenzaldehyde /7.98 g, 48 mmol),
CaSO4 /Drieritee) /10.9 g) and MeCN /75 ml) and re¯uxed
for 4.5 h. After allowing to cool to room temperature, the
reaction mixture was concentrated in vacuo. To the residue
was added CH2Cl2 and the insoluble matter was ®ltered off.
The ®ltrate was washed with 0.1N-NaOH and water, dried
over anhydrous Na2SO4 and concentrated in vacuo. The
residue was washed with EtOH to give the target compound
/4.51 g) /61% based on 8) as a yellow crystalline powder.
4.2.5. 6-Bromo-7-chloro-2-/3,4-dimethoxyphenyl)-4-/2-
pyridyl)-2H-1,3-benzoxazine /10f). A yellow crystalline
powder: mp 218±2208C, 1H NMR /CDCl3, TMS,
300 MHz), d /ppm): 3.96 /3H, s), 3.98 /3H, s), 6.70±6.74
/1H, m), 6.93±6.98 /1H, m), 7.02±7.04 /1H, m), 7.15 /1H,
s), 7.26 /1H, d, J1.8 Hz), 7.30±7.33 /1H, m), 7.88±7.90
References
/1H, m), 7.94 /1H, s), 8.28±8.30 /1H, m), IR /KBr, cm21
)
1. /a) Yamamoto, S.; Hashiguchi, S.; Miki, S.; Igata, Y.; Wata-
nabe, T.; Shiraishi, M. Chem. Pharm. Bull. 1996, 44, 734.
/b) Kusumoto, K.; Awane, Y.; Kitayoshi, T.; Fujiwara, S.;
Hashiguchi, S.; Terashita, Z.; Shiraishi, M.; Watanabe, T.
J. Cardiovasc. Pharmacol. 1994, 24, 929.
1511, 1265, 1027, MS /EI, m/z): 462 /M14), 460 /M12),
458 /M), Elemental analysis: calcd for; C: 54.87, H: 3.51, N:
6.09, found for C: 54.95, H: 3.55, N: 6.16,
4.2.6. Spiro[4-phenyl-2H-1,3-benzoxazine-2,20-adaman-
tane]/10g). Triethylamine /25.5 g, 252 mmol) was added
to the stirred suspension of 2-hydroxybenzo-phenone 8f
/10 g, 50.4 mmol), ammonium iodide /36.5 g, 252 mmol),
CaSO4 /Drieritee) /31.6 g, 232 mmol) and MeCN /150 ml),
and stirred at room temperature for 44.5 h. To the resulting
mixture was added 2-adamatanone /22.7 g, 151 mmol) and
MeCN /50 ml), and re¯uxed for 3 h. After allowing to cool
to room temperature, the insoluble matter in the reaction
mixture was ®ltered off and washed with MeCN. The
mixture of the ®ltrate and washings was concentrated in
vacuo. To the residue were added diisopropyl ether and
0.1N-NaOH; and separated into the organic and aqueous
layers. The organic layer was washed with 0.1N-NaOH
and water, dried over anhydrous Na2SO4 and concentrated
in vacuo. The residue was washed with EtOH to give the
target compound 10f /11.6 g, yield 70%) as a colorless crys-
2. /a) Baumgarth, M., Gericke, R., Bergmann, R., De Peyer, J.,
Ingeborg, L. DE3840011/CA114/17):164256m). /b) Englert,
H. C., Mania, D., Lintz, W. DE4010488/CA116/5):41463k).
3. /a) Melzig, M. WO90-03379/CA114/5):42796s). /b) Kaneko,
Y. JP88-284547/CA111/8):67818b). /c) Tachikawa, R.; Wachi,
K.; Sato, S.; Terada, A. Chem. Pharm. Bull. 1981, 29, 3529.
4. Kabbe, H. J.; Widdig, A. Angew. Chem., Int. Ed. Engl. 1982, 21,
247.
5. General review: /a) Adam, W.; Curci, R.; Edwards, J. O. Acc.
Chem. Res. 1989, 22, 205. /b) Murray, R. W. Chem. Rev. 1989,
89, 1187. /c) Curci, R. Pure Appl. Chem. 1995, 67, 811.
6. Selective N-oxidation of pyridine derivatives bearing ole®n
moiety: /a) Ferrer, M.; Sanchez-Baeza, F.; Messrguer, A.
Tetrahedron 1997, 46, 15877. Selective N-oxidation of 3- or
4-picolinaldehyde: /b) Dyker, G.; Hoelzer, B. Tetrahedron
1999, 55, 12557.
1
7. /a) Attwood, M. R.; Churcher, I.; Dunsdon, R. M.; Hurst, D. N.;
Jones, P. S. Tetrahedron Lett. 1991, 32, 811. /b) Takahashi, T.;
Koga, H.; Sato, H.; Ishizawa, T.; Taka, N. Heterocycles 1995,
41, 2405. /c) Almansa, C.; Gomez, L. A.; Cavalcanti, F. L.;
Rodriguez, R.; Garcia-Rafanell, J.; Forn, J. Bioorg. Med.
Chem. Lett. 1995, 5, 1833.
talline powder: mp 171±1738C, H NMR /CDCl3, TMS,
300 MHz), d /ppm): 1.57±1.59 /6H, m), 1.93±1.98 /2H,
m), 2.23±2.30 /4H, m), 2.44±2.48 /2H, m), 6.92±7.01
/2H, m), 7.23±7.26 /2H, m), 7.38±7.46 /3H, m), 7.63±
7.66 /2H, m), IR /KBr, cm21) 2902, 1610, 1334, 700, MS
/EI, m/z):329 /M1), Elemental analysis: calcd for; C: 83.85,
H: 7.04, N: 4.25, found for C: 83.80, H: 6.91, N: 4.07.